chr2-241096078-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182501.4(MTERF4):āc.1066A>Gā(p.Asn356Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000231 in 1,602,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_182501.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTERF4 | NM_182501.4 | c.1066A>G | p.Asn356Asp | missense_variant | 4/4 | ENST00000391980.7 | NP_872307.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTERF4 | ENST00000391980.7 | c.1066A>G | p.Asn356Asp | missense_variant | 4/4 | 1 | NM_182501.4 | ENSP00000375840.2 |
Frequencies
GnomAD3 genomes AF: 0.0000943 AC: 14AN: 148428Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250118Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135320
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1454078Hom.: 0 Cov.: 31 AF XY: 0.0000125 AC XY: 9AN XY: 722850
GnomAD4 genome AF: 0.0000943 AC: 14AN: 148428Hom.: 0 Cov.: 32 AF XY: 0.0000690 AC XY: 5AN XY: 72512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.1066A>G (p.N356D) alteration is located in exon 4 (coding exon 4) of the MTERF4 gene. This alteration results from a A to G substitution at nucleotide position 1066, causing the asparagine (N) at amino acid position 356 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at